Sector News

GSK dodges UK strike with improved pay offer for staffers

May 29, 2022
Life sciences

GSK has averted an industrial kerfuffle in the United Kingdom.

A potential strike by more than 1,000 GSK engineers, technicians, laboratory analysts, warehouse workers and others has been called off after the employees—represented by Britain and Ireland’s biggest labor union Unite—accepted an improved pay offer from the British Big Pharma.

The staffers voted to strike last month after receiving a “derisory” pay raise offer of 2.75%, according to Unite. That sum was well below the U.K.’s rate of inflation, which clocked in at nine percent in late April, the labor union said at the time.

Now, following fresh negotiations, GSK has lifted its offer, Unite said Monday.

“We are pleased to have reached an agreement with our employees covered by collective bargaining agreements at UK manufacturing sites,” a GSK spokesperson said over email. “We are committed to maintaining positive relationships with our skilled manufacturing workforce and the unions that represent them.”

GSK said the updated offer consists of a 4.5% increase to base salary, which is backdated. Further, the deal includes a one-off special award to all GSK employees of one week’s pay, which is worth about 2% of base salary.

“Unite will be using this settlement as a stepping stone to ensure that in all future pay settlements GSK properly rewards its workforce,” Tony Devlin, Unite national officer, said in a statement in the union’s release.

There are about 700 GSK staffers in Unite, the company’s spokesperson told Fierce Pharma last month. About 500 members voted in last month’s strike bid, with 430 in favor of taking action. GSK has about 175 members in fellow U.K. trade union GMB, who did not vote for strike action, the company noted.

Last month, GSK provided a slightly different take on the potential strike. The company said it had offered a 4% increase to base salary—not the 2.75% bump reported by Unite—plus a one-off award worth about 2% of base salary. The company had also floated an annual bonus for 2021 that “paid out above-target,” the spokesperson explained via email.

GSK employs around 13,000 people in the U.K., some 3,500 of whom work at manufacturing sites, the spokesperson added.

By Fraiser Kansteiner

Source: fiercepharma.com

comments closed

Related News

June 8, 2024

Lilly CFO leaves to join Alphabet

Life sciences

Anat Ashkenazi will leave Eli Lilly’s executive suite at the end of July to become CFO and senior vice president of Google and Alphabet. Ashkenazi has been CFO at Lilly since 2021 and originally joined the company in 2001. Over her 23-year career at the Indianapolis-based drugmaker, Ashkenazi also served as controller, CFO of Lilly Research Laboratories and as the finance chief for several global divisions within the company.

June 8, 2024

Edwards Lifesciences to cell Critical Care to BD

Life sciences

Edwards Lifesciences (NYSE: EW) announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care.

June 8, 2024

Danaher names Martin Stumpe as chief data and AI officer

Life sciences

The company, which owns diagnostics and life sciences businesses including Beckman Coulter and Cepheid, said the appointment reflects its increasing investment in AI as “a driving force for innovation and productivity.” Danaher is focused on AI by also spending on its internal capabilities and partnering with academic groups.

How can we help you?

We're easy to reach